273 related articles for article (PubMed ID: 32613742)
1. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
[TBL] [Abstract][Full Text] [Related]
2. Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris.
Chen T; Guo ZP; Li L; Wang L; Jia RZ; Cao N; Qin S; Li MM
Arch Dermatol Res; 2013 Apr; 305(3):263-7. PubMed ID: 23440398
[TBL] [Abstract][Full Text] [Related]
3. Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis.
Kawasaki Y; Kamata M; Shimizu T; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Oct; 47(10):1149-1156. PubMed ID: 32677127
[TBL] [Abstract][Full Text] [Related]
4. Increased neutrophil-derived IL-17A identified in generalized pustular psoriasis.
Lan Y; Wu X; Zhong X; Song P; Liu L; Liu Y; Ai X; Han C; Zhang Z
Exp Dermatol; 2024 Feb; 33(2):e15026. PubMed ID: 38414093
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and heterogeneity of generalized pustular psoriasis: A comparative study in a large retrospective cohort.
Xu Z; Liu Y; Qu H; Bai Y; Ma J; Hao J; Yu C; Dang E; Wang G; Shao S
Exp Dermatol; 2024 Jan; 33(1):e14891. PubMed ID: 37493071
[TBL] [Abstract][Full Text] [Related]
6. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
7. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database.
Wang HM; Xu JM; Jin HZ
Am J Clin Dermatol; 2023 Nov; 24(6):991-1002. PubMed ID: 37386353
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020.
Choon SE; Wright AK; Griffiths CEM; Wong KW; Tey KE; Lim YT; Chua KY; Ashcroft DM
Br J Dermatol; 2023 Sep; 189(4):410-418. PubMed ID: 37162007
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.
Ohata C; Tsuruta N; Yonekura K; Higashi Y; Saito K; Katayama E; Imafuku S;
J Dermatol; 2022 Jan; 49(1):142-150. PubMed ID: 34723399
[TBL] [Abstract][Full Text] [Related]
11. Different Clinical Features of Pediatric Generalized Pustular Psoriasis in Patients with or without IL36RN Variants.
Wang Z; Xiang X; Chen Y; Qi Z; Miao C; Liu Y; Zhao X; Zhang Y; Zhang Z; Li W; Xu Z; Ma L
Dermatology; 2023; 239(2):217-226. PubMed ID: 36577391
[TBL] [Abstract][Full Text] [Related]
12. Circulating Metabolomic Signature in Generalized Pustular Psoriasis Blunts Monocyte Hyperinflammation by Triggering Amino Acid Response.
Yu N; Peng C; Chen W; Sun Z; Zheng J; Zhang S; Ding Y; Shi Y
Front Immunol; 2021; 12():739514. PubMed ID: 34567002
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Generalized Pustular Psoriasis.
Fujita H; Gooderham M; Romiti R
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):31-38. PubMed ID: 35061226
[TBL] [Abstract][Full Text] [Related]
14.
Kantaputra P; Daroontum T; Chuamanochan M; Chaowattanapanit S; Kiratikanon S; Choonhakarn C; Intachai W; Olsen B; Tongsima S; Ngamphiw C; Pontisso P; Cox TC; Ounjai P
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833193
[TBL] [Abstract][Full Text] [Related]
15. Clinical Disease Measures in Generalized Pustular Psoriasis.
Burden AD; Choon SE; Gottlieb AB; Navarini AA; Warren RB
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):39-50. PubMed ID: 35061231
[TBL] [Abstract][Full Text] [Related]
16. Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report.
Adi G; Shaath MR; Adi K; Obaid Z; Aldosari E; AlKateb FA
Front Immunol; 2024; 15():1337799. PubMed ID: 38571950
[TBL] [Abstract][Full Text] [Related]
17. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
18. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.
Johnston A; Xing X; Wolterink L; Barnes DH; Yin Z; Reingold L; Kahlenberg JM; Harms PW; Gudjonsson JE
J Allergy Clin Immunol; 2017 Jul; 140(1):109-120. PubMed ID: 28043870
[TBL] [Abstract][Full Text] [Related]
19. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris.
Li X; Chen M; Fu X; Zhang Q; Wang Z; Yu G; Yu Y; Qin P; Wu W; Pan F; Liu H; Zhang F
J Dermatol Sci; 2014 Nov; 76(2):132-8. PubMed ID: 25212972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
